Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 5 results for "praful bohra"

Investors Overlook Lupin's Q4 Beat, Shares Tumble Over 9%

Lupin's Goa plant is under US drug regulator's scanner Lupin shares sank over 8 per cent on Friday, even though analysts described the drugmaker's Q4 results as positive. Lupin, India's third-largest drugmaker, reported a higher than expected ... NDTV Profit, 1 week ago
Goa plant woes a key overhang on Lupin: Experts, 1 week ago

Venezuelan write-offs hit Dr Reddy's Q4 numbers:Experts

Dr Reddy's Pathlabs reported a sharp decline in its net profit of FY16 at Rs 74.6 crore over Rs 518.9 crore a year ago, due to one-time write-offs of Rs 430.9 crore from its Venezuelan business. The company has mentioned in its earnings report that ...
 Moneycontrol.com2 weeks ago

'Glenmark to profit from drug price hike, +ve on Sun Pharma'

The decision by Taro Pharma, Sun Pharma's Israeli subsidiary, to provide keveyis free of cost to distributors is likely to impact revenues of about USD 25 million, says Praful Bohra, VP Research at Religare.
 Money Control3 weeks ago

FDC ban not done in proper manner; large brands to suffer: Pros

The government over the weekend banned 344 Fixed Dose Combinations (FDCs) drugs, which will impact nearly 4-5 percent of the Indian pharmaceutical industry. Kewal Handa, industry expert and former MD of Pfizer says that alongwith sales loss, ...
 Moneycontrol.com2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less